Status:
UNKNOWN
Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
Lead Sponsor:
Tokushukai Medical Group
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
Contrast-Induced Acute Kidney Injury(CIAKI) was defined as an absolute increase in serum creatinine of more than or equal to 0.3mg/dl (≥ 26.4 μmol/l), a percentage increase in serum creatinine of more...
Eligibility Criteria
Inclusion
- serum creatinine more or equal than 1.1mg/dL
- procedures using contrast media
Exclusion
- congestive heart failure
- serum creatinine less than 1.1mg/dl
- allergy to contrast media
- preexisting dialysis
- emergency catheterization
- recent exposure to contrast within 2 days of the study
- refuse to entry this study
- PTRA
- dialysis after procedure
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2014
Estimated Enrollment :
458 Patients enrolled
Trial Details
Trial ID
NCT01210456
Start Date
October 1 2009
End Date
November 1 2014
Last Update
September 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sapporo Higashi Tokushukai Hospital
Sapporo, Hokkaido, Japan, 065-0033